Abstract:Homeodomain transcription factor A9 (HOXA9) is a member of the HOX cluster family of transcription factors that are crucially involved in embryo implantation, morphogenesis, body axis development, and endothelial cell differentiation. Despite numerous reports on its aberrant expression in a few malignancies, the molecular and functional complexity of HOXA9 across cancers remains obscure. We aimed to analyze the dynamic role of HOXA9 across cancers by identifying, analyzing, and understanding its multiple modes of regulation and functional implications and identifying possible therapeutic avenues. We conducted a comprehensive analysis to determine the role of HOXA9 across cancers. This approach involved the integration of large-scale datasets from public repositories such as the Genomic Data Commons, specifically the Cancer Genome Atlas (GDC-TCGA), across 33 different cancer types. The multiple modes of HOXA9 regulation by genetic and epigenetic factors were determined using online tools, which comprised experimentally validated observations. Furthermore, downstream pathways were identified by predicting the targets of HOXA9 and by performing functional enrichment analysis. We also assessed the clinical significance of HOXA9 in terms of prognosis and stage stratification. This study evaluated the correlation between HOXA9 and tumor-infiltrating molecules and discussed its association with therapeutically approved antineoplastic drugs. HOXA9 was significantly upregulated in 9 tumors and downregulated in 2 cancers. The deregulation of HOXA9 is primarily attributed to epigenetic factors, including promoter DNA methylation and noncoding RNAs (ncRNAs). The HOXA9 transcription factor interacts with PBX/MEIS cofactors and regulates multiple genes involved in cancer-associated EMT, autophagy, the cell cycle, metabolic pathways, Wnt signaling, TGF-β signaling, the AMPK pathway, PI3K/AKT signaling, and NF-κB signaling, thereby establishing control over downstream mechanisms. Differential expression in various clinical stages across cancers was shown to have prognostic significance and to be correlated with tumor-infiltrating immune molecules. The assessment of the correlation of HOXA9 expression with approved antineoplastic drugs revealed that targeting HOXA9 could be the most reliable strategy for preventing cancer progression. HOXA9 is upregulated in the majority of malignancies and drives cancer progression by regulating multiple signaling mechanisms. Hence, HOXA9 could be a reliable diagnostic indicator and a potential therapeutic candidate for solid cancer types.

Significance of HOXD transcription factors family in progression, migration and angiogenesis of cancer

HOX family transcription factors: Related signaling pathways and post-translational modifications in cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

FOXN Transcription Factors: Regulation and Significant Role in Cancer

The Role of HOX Transcription Factors in Cancer Predisposition and Progression

Role of HOXA1-4 in the development of genetic and malignant diseases

Role of HOX genes in cancer progression and their therapeutical aspects

Role of HOX Genes in Tumor Genesis and Development

Emerging Role of HOX Genes and Their Related Long Noncoding RNAs in Lung Cancer

HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target

LIM homeobox transcription factors, a novel subfamily which plays an important role in cancer (review).

Recent Advancements in Understanding of Biological Role of Homeobox C9 in Human Cancers

The Role of HOPX in Normal Tissues and Tumor Progression

Research Progress on HOX Family and Cancer

The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer

A narrative review of the roles of muscle segment homeobox transcription factor family in cancer

Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis

Role of homeobox genes in cancer: immune system interactions, long non-coding RNAs, and tumor progression

HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis

Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review

HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans.